Although the specific mechanisms hMOF plays in tumor development and progression are unclear, several studies demonstrate that abnormal hMOF gene expression in various cancers, including breast, renal cell, colorectal, gastric, and non-small cell lung cancer [39–42]. Here, KAT8 is linked to non-small cell lung carcinoma.